As a physician-scientist and biotech executive, I have dedicated my career to bridging the gap between groundbreaking medical research and commercial success. From securing multimillion-dollar funding to leading strategic M&A deals, my passion lies in driving healthcare innovation that delivers real-world impact. Here is my biography.

Matthew Smollin, PharmD, is an accomplished leader in medical affairs and clinical innovation with over 15 years of clinical experience and a decade of industry expertise spanning clinical research, regulatory strategy, and team leadership. As Vice President of Medical Affairs at Karius, Inc., he directs medical and scientific strategies, guiding breakthrough advancements in molecular diagnostics while navigating complex FDA and Medicare regulatory processes. Throughout his career, he has successfully built and managed high-performing teams, fostered strong relationships with key opinion leaders, and played a pivotal role in clinical trial design, publication strategy, and scientific engagement. A respected speaker and thought leader, Dr. Smollin’s expertise in infectious disease diagnostics and next-generation sequencing has shaped industry best practices and advanced clinical innovation. His dedication to scientific excellence, strategic vision, and ability to translate complex medical insights into impactful solutions make him a driving force in the evolution of precision medicine and diagnostic technologies.

Excited to share my professional journey in NGS cancer diagnostics, biotech, and healthcare innovation! With over 20 years of experience spanning product management, AI-driven automation, clinical trials, and regulatory compliance, I have led multi-billion-dollar product launches and driven transformative advancements in precision medicine and oncology. My expertise in agile methodologies, strategic planning, and cross-functional leadership has enabled me to bridge science and business for impactful solutions. Here is my biography.

I'm excited to share my journey and experiences in oncology, cancer research, and precision medicine. Over the past 32 years, I’ve had the privilege of founding and leading institutions dedicated to advancing cancer care and improving patient outcomes through innovative research and clinical trials. From my work at the Kentucky Cancer Group to my time as Director of Precision Medicine at Norton Cancer Institute, I’ve focused on integrating cutting-edge therapies and a compassionate approach to oncology. Check out my executive biography to learn more about my work and how I'm committed to pushing the boundaries of cancer care through leadership and collaboration.